NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
Authors
Keywords
-
Journal
Chemical Science
Volume 6, Issue 9, Pages 5120-5127
Publisher
Royal Society of Chemistry (RSC)
Online
2015-06-25
DOI
10.1039/c4sc03599b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
- (2014) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides
- (2014) Lisa Kain et al. IMMUNITY
- A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
- (2014) Regan J Anderson et al. Nature Chemical Biology
- A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice
- (2014) Marco Cavallari et al. Nature Chemical Biology
- Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
- (2014) Josianne Nitcheu Tefit et al. VACCINE
- Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
- (2014) G. G. Zom et al. Cancer Immunology Research
- Immunological targeting of cytomegalovirus for glioblastoma therapy
- (2014) Smita K Nair et al. OncoImmunology
- Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid
- (2013) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Direct Peptide Lipidation through Thiol-Ene Coupling Enables Rapid Synthesis and Evaluation of Self-Adjuvanting Vaccine Candidates
- (2013) Tom H. Wright et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy
- (2013) R. Weinkove et al. HAEMATOLOGICA
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
- (2011) Brendan L. Wilkinson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- An improved synthesis of dansylated α-galactosylceramide and its use as a fluorescent probe for the monitoring of glycolipid uptake by cells
- (2011) Janice M.H. Cheng et al. CARBOHYDRATE RESEARCH
- First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-livedMycobacterium tuberculosis-specific Th1-cell like responses
- (2011) Tom H. M. Ottenhoff et al. Human vaccines & immunotherapeutics
- A Modular Approach to Assembly of Totally Synthetic Self-adjuvanting Lipopeptide-based Vaccines Allows Conformational Epitope Building
- (2011) Weiguang Zeng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tailored Ligand Acceleration of the Cu-Catalyzed Azide−Alkyne Cycloaddition Reaction: Practical and Mechanistic Implications
- (2010) Stanislav I. Presolski et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
- (2010) Jaap T. van Dissel et al. VACCINE
- RCAI-17, 22, 24–26, 29, 31, 34–36, 38–40, and 88, the analogs of KRN7000 with a sulfonamide linkage: Their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines
- (2008) Takuya Tashiro et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand
- (2008) Jeong-Ju Park et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More